Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Indivior (INDV) Share News

CORRECT: Indivior shares down on swing to annual loss

16th Feb 2023 10:10

(Correcting litigation provision is against 2022 results.) Read More

TOP NEWS: Indivior shares down on swing to annual loss

16th Feb 2023 10:09

(Alliance News) - Indivior PLC on Thursday reported a swing to a full-year loss due to a provision for litigation, despite net revenue jumping by 14% due to growth in its Sublocade injection. Read More

LONDON MARKET OPEN: FTSE 100 tops 8,000; Centrica is star performer

16th Feb 2023 08:49

(Alliance News) - Stock prices in London opened higher on Thursday, with London's blue-chip index pushing past the 8,000 mark once again, a day after it first broke the barrier. Read More

LONDON BRIEFING: Centrica, Indivior swing to loss; StanChart bullish

16th Feb 2023 07:55

(Alliance News) - Stocks in London were set to open higher on Thursday, with the FTSE 100 called to push past the 8,000 mark again at the open. Read More

UK earnings, trading statements calendar - next 7 days

9th Feb 2023 15:47

Indivior announces expiry of waiting period for Opiant purchase

6th Feb 2023 16:32

(Alliance News) - Indivior PLC has announced on Monday the expiration of the waiting period relating to its USD145 million purchase of Opiant Pharmaceuticals Inc. Read More

LONDON MARKET CLOSE: Pharma stocks fail to lift FTSE 100 in the green

7th Dec 2022 17:25

(Alliance News) - Stocks in London closed in the red on Wednesday, despite a strong performance from pharmaceutical stocks, as investors digested a raft of economic data from both China and Europe. Read More

Indivior targets Nasdaq listing for spring 2023 as hails Sublocade

7th Dec 2022 11:44

(Alliance News) - Indivior PLC on Wednesday said it aims to list on the Nasdaq in spring 2023 as it expects its injection Sublocade to reach peak annual net revenue of over USD1.5 billion. Read More

Indivior buys Opiant creating "comprehensive" treatment platform

14th Nov 2022 11:16

(Alliance News) - Indivior PLC on Monday announced the acquisition of Opiant Pharmaceuticals Inc for around USD145 million. Read More

LONDON BROKER RATINGS: RBC and JPMorgan up Lloyds Banking price target

28th Oct 2022 10:07

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon: Read More

TOP NEWS: Indivior ups annual guidance on "strong momentum"

27th Oct 2022 11:05

(Alliance News) - Indivior PLC on Thursday reported a double-digit rise in both quarterly net revenue and profit, as it raises its full-year guidance. Read More

UK earnings, trading statements calendar - next 7 days

20th Oct 2022 15:59

UK shareholder meetings calendar - next 7 days

23rd Sep 2022 15:58

UK shareholder meetings calendar - next 7 days

23rd Sep 2022 15:58

LONDON BROKER RATINGS: RBC resumes National Express at 'outperform'

2nd Aug 2022 09:44

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

Indivior shares down amid drop in interim profit; eyes US listing

28th Jul 2022 12:58

(Alliance News): Indivior PLC on Thursday reported a "strong" performance in the first half of 2022, even as profit fell due to by investments in opioid mediation Sublocade. Read More

LONDON BRIEFING: Shell launches GBP6 billion buyback as earnings soar

28th Jul 2022 08:22

(Alliance News) - Shell on Thursday said earnings surged by two-thirds in the first half of 2022, as the oil major continued to benefit from a sharp rise in oil prices following Russia's invasion of Ukraine. Read More

UK earnings, trading statements calendar - next 7 days

21st Jul 2022 16:10

IN BRIEF: Indivior amends relationship deal with shareholder Scopia

7th Jul 2022 18:27

Indivior PLC - Richmond, Virginia-based pharmaceutical firm - Amends existing relationship agreement with largest shareholder Scopia Channel Management LP. Read More

IN BRIEF: Indivior settles patent infringement case with DRL

24th Jun 2022 12:40

Indivior PLC - Richmond, Virginia-based pharmaceutical firm - Enters into a settlement agreement with Indian pharmaceutical company Dr Reddy's Laboratories Ltd and its subsidiaries together with Aquestive Therapeutics Inc. Explains that the settlement is for a patent infringement case regarding DRL's generic buprenorphine and naloxone sublingual film that is equivalent to its Suboxone sublingual film. Read More

FTSE 100 Latest

Value8,275.66

Change0.00